AFX.DE Reddit Mentions

Track AFX.DE's AI-powered predictions, market trends, and investment insights.

AFX.DE AI Prediction AFX.DE Sentiment AFX.DE StockTwits

Mock Tradesimulated, no real money

You don't hold AFX.DE in your mock portfolio yet.

AFX.DE Reddit Mentions

Track AFX.DE's AI-powered predictions, market trends, and investment insights.

AFX.DE AI Prediction AFX.DE Sentiment AFX.DE StockTwits

Evidence Stack

What Changed?

Key moves vs recent baseline (last day / last week)

Price (1d)0.7%

Price (7d)-6.5%

Volume vs avg0.8x

Reddit mentions vs 7D+0%

Volatility vs normal1.0x

Why Now?

Plain-English summary of the biggest drivers (informational)

Risk Flags

Potential risk factors to review

No flags triggered by these checks.

Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.

Invalidation Signals

Reassess your thesis if any of these occur:

Price breaks below ~€24.82 (recent support level)

Upgrade to see the full Evidence Stack

What Changed, Why Now, and Risk Flags — available on the Investor plan and above

Get Started

AFX.DE AI Stock Analysis

Financial Performance

neutral

With EPS of €1.61 and a PE of 16.16, Carl Zeiss Meditec AG appears reasonably valued relative to earnings, suggesting neither clear undervaluation nor overvaluation based solely on these metrics. Profitability exists but the modest multiple implies the market is not pricing in aggressive growth, pointing to a balanced risk‑reward profile at current fundamentals.

EPS of €1.61 indicates the company is solidly profitable, providing an earnings base to support the current share price.
A PE ratio of 16.16 is roughly in line with a mature, quality industrial/medtech name, suggesting the market expects steady but not explosive growth.
No explicit revenue or margin data are provided, but the combination of positive EPS and a mid‑teens PE implies stable, rather than high‑growth, financial performance.

Stock Price & Technicals

bearish

The stock trades at €26.02, materially below its 200‑day moving average of €35.69, signaling a pronounced downtrend. A 6.7% decline over the last month reinforces negative momentum, and the large gap to the long‑term average suggests sentiment and technicals are currently unfavorable.

Current price of €26.02 is significantly below the 200‑day moving average of €35.69, a classic sign of a sustained downtrend and technical weakness.
The stock is down 6.7% over the last month, indicating continued selling pressure and lack of near‑term positive catalysts in price action.
Given the sharp discount to the 200‑day average, the RSI (not provided) is likely in or near oversold territory, but without a clear reversal pattern the setup remains technically bearish rather than a confirmed bounce opportunity.

Alternative Data Signals

bullish

Alternative data points to a company that is actively growing its digital footprint and operational capacity, despite recent share price weakness. Rising job openings, steady app downloads, and generally expanding social media audiences suggest ongoing investment and engagement that are more consistent with a constructive medium‑term outlook.

Job openings at 357, up 4.7% month over month, indicate active hiring and potential expansion, a positive signal for future growth and confidence in the business pipeline.
Mobile apps are being downloaded an estimated 10,000 times per day, implying strong and ongoing user engagement with the company’s digital ecosystem, which can support product adoption and brand strength.
Social media presence is broadly growing (Instagram +3.3%, YouTube +1.8%, small gains on Twitter/X and Facebook, slight dip on TikTok), suggesting stable to improving brand awareness and customer engagement rather than deterioration.

Conclusion

neutral

Fundamentals and alternative data for Carl Zeiss Meditec AG appear reasonably solid, but the stock is in a clear technical downtrend and trades well below its long‑term moving average. Overall, the picture is neutral: operational and engagement indicators are constructive, yet price action and sentiment remain weak, leaving the balance between risk and opportunity finely poised.

Operational signals (hiring growth, strong app downloads, and expanding social media reach) lean constructive and support a longer‑term positive business outlook.
Technical indicators are currently bearish, with the share price significantly below the 200‑day moving average and recent negative momentum, tempering the otherwise supportive alternative and earnings data.

AI Score

Hold

Alternative7

Fundamental8

Technical3

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.

Mock Tradesimulated, no real money

You don't hold AFX.DE in your mock portfolio yet.